Top Device Companies

Life Science Mergers and Acquisitions: How Health Care Reform will Change your Partnering Strategy

Health care reform has become law in the United States. And, putting aside the politics, you know your business is about to change in many ways. If you’re pursuing, or considering a merger, acquisition, joint venture, or collaboration agreement, or concerned with changes in reimbursement—what is covered, for whom, and for how much...

Off-Label Promotion: Dos & Don'ts for Monitoring and Maintaining Promotional Compliance

Your company has clear rules and procedures on promotional compliance, and none of your staff violates them, right?

Medical Device Landscape: How regulatory changes and cost control measures are reshaping the industry

Elsevier Business Intelligence announces the publication
of a new Special Report:

Medical Device Landscape:
How regulatory changes and cost control measures
are reshaping the industry

Originally published in Medtech Insight: Medical Technology Market Intelligence®

While the insurance industry and Big Pharma make headlines during the health care reform debate, medical device manufacturers shouldn't relax their guard for even a moment: From the rising clout of group purchasing organizations (GPOs) to payment bundling and physicians' growing allegiance with hospitals in product price negotiations, the device market is facing some of the most serious challenges to its profits in years. How aggressive will GPOs get with device companies? How has the tough economy impacted medical device funding? And what can manufacturers do to help insure their success in this rapidly shifting environment? This Special Report answers all these questions and more with in-depth analysis of the impact of new device regulations combined with new moves among payors to lower costs.

This detailed 24-page report is a must-read for every medical device reimbursement, marketing, sales, business development and investment executive in medical technology today, whether you're a device start up seeking funding, an orthopedics executive struggling with the new device industry-physician transparency laws, or even a sales rep wondering why your clients have stopped returning your calls.

Prepared by Medtech Insight’s expert analysts, the report spotlights how a vast range of cost-cutting, ethics and health care reform measures are impacting the medical device industry, and forecasts potential longterm effects of the upheaval.

This Special Report examines ...

• How the bond between group purchasing organizations and hospitals is growing stronger every day, and how the burden of cost-cutting is now shifting from health care providers to medical device manufacturers themselves
• CMS' three-year pilot program that will experiment with single, bundled-payment systems for selected hospitals serving orthopedic and cardiac patients
• The plethora of new rules and regulations governing medical device companies and their relationships with physicians, and how to stay on the right side of the law
• Why physicians are suddenly less likely to purchase high-priced medical devices based on their own preferences, as in the past, and are instead working with hospital management to develop low-cost purchasing plans
• The perilous state of medical device funding, from health care reform's dampening effect on investor enthusiasm to the economy-based decline of once-reliable device VCs...and much more.

Click here to ORDER NOW

It's all about the margins

What's driving hospitals into the arms of aggressive GPOs? According to one GPO CEO, it's a rising tide of bitterness at some hospitals  toward manufacturers operating on high margins, but still trying to pass along increasing costs to facilities  struggling financially. Nevertheless, this provides an unexpected opportunity for device manufacturers who are willing to work with providers in cutting costs to actually increase their market share.

The threat to medical device innovation

Some changes coming down the pike as part of health care reform could benefit hospitals, physicians and patients, but what effect will they have on medical device manufacturers? The device industry worries that letting hospitals make gang decisions through payment bundling will cut them out of the decision-making process altogether, creating an arid landscape for new technology and innovation.

Is it an educational seminar or a golf outing?

What's a device manufacturer and its sales force to do? Now that the health care regulatory watchdogs have spoken, pretty much any traditional gifts, remunerations or consulting contracts with physicians are off-limits. This report outlines the penalties already paid by prominent device companies and explains that the scrutiny is getting even harsher. The solution for confused executives? The "common-sense" or "straight face" tests that you should use to decide what's ethical and what will get you into hot water.

From product selection process to medical device startup investment trends, these are just some of the issues and actionable insight included in this must-read report. And it could only be delivered by Medtech Insight, the premier resource for medical technology intelligence, relied on by executives at a majority of the top 50 medtech companies in the world.

ORDER NOW

U.S. Home Healthcare Products Market Report

The combined U.S. market for home healthcare products reached $4.3 billion in 2007 and (despite current economic recession and uncertainty), is expected to expand at a compound annual growth rate of more than 4%, reaching nearly $5.2 billion in 2012. It is one of the largest and most stable in the United States (U.S.) due to the burgeoning aging population and corresponding increase in lifespan, the critical need for cost-effective medical equipment for patients suffering from long-term chronic conditions, and the increasing usage of technology by the baby-boomer population.

 
Several homecare product markets are expected to benefit from demographic and healthcare trends. In particular, six (6) core homecare product areas are expected to exhibit market growth over the next five (5) years. Market intelligence Report A371 from Medtech Insight includes analyses of products, current and emerging markets, competitors, and opportunities in the U.S. homecare products market. Product areas include those noted in the condensed Table of Contents (TOC) below. … Read More

U.S. Diabetes Management Products Market Report

Diabetes affects nearly 24 million people in the U.S. and is the 5th leading cause of death by disease in the U.S. This costs the U.S. healthcare system more than $130 billion per year. To constrain spiraling healthcare costs, the development of more affordable and effective diabetes management (self-testing and treatment) products has become a top priority not only in the U.S., but worldwide. Diabetes management products have become one of the largest medical device and pharmaceutical markets in the U.S., totaling more than $15 billion. As the population of diabetics continues to increase, the market is expected to continue to grow at a double-digit rate over the next five years, reaching nearly $28 billion by 2013.

Medtech Insight's market intelligence Report A376 thoroughly examines the U.S. markets, competitors, opportunities, and product areas of self-testing blood glucose monitoring systems, continuous blood glucose monitoring systems, insulin therapies, insulin injection devices, insulin pumps, injectable/oral diabetes drugs, and emerging diabetes drugs and technologies, including pancreatic islet cell transplantation. . … Read More

       

Airway Management & Ventilation Products (Europe)

Airway management and ventilation products are reportedly on track to become a $534 million market. Now you can understand it from every angle with this new report from Medtech Insight, the leading and most trusted provider of off-the-shelf medical technology market reports available today.

It is a must-read for all senior executives in business development, product development, marketing, pricing, and reimbursement and regulatory affairs in the respiratory, critical care and emergency care sectors, as well as suppliers and investors. Read this report to learn about:

 

· Which sectors are expected to grow fastest, and by how much.

· Which factors are impacting the growth of the European markets.

· Which features and characteristics of ventilators are becoming most important to purchasers.

· Who already has a position in the market, their market share, and their most successful products.

· Which specific products are in greatest demand.

· Average prices for ventilators across Europe.

· Specific market forecasts for each of the five largest EU countries through 2013, across a range of products.

· Which countries offer the biggest opportunities for growth.

· Why price-based competition will continue to grow even in the economically-united EU countries.

· How to tailor marketing to meet growing cost-effectiveness concerns.

· How managed care will affect device markets in the future.

· M&A activity among the current leading manufacturers.

 

Plus 12 company profiles of the major players and much more! Read More

Oncology Outlook: How Cutting-Edge Medical Technology Is Improving the Odds for Cancer Patients

 

Elsevier Business Intelligence announces the publication
of a new Special Report:

Oncology Outlook:
How Cutting-Edge Medical Technology Is
Improving the Odds for Cancer Patients

FDA Advisory Committee Survival Strategies: The Road To Approval

NEW EBI Webinar: FDA Advisory Committee Survival Strategies: The Road To Approval

January 20, 2010 at 2:00 pm EDT Click Here To Register!

Getting a drug or medical device to market has never been more expensive, time-consuming, or difficult. New legislation increases the likelihood that your product will wind up in front of an FDA advisory committee. With the road to approval becoming even tougher, just having solid data to support your product may not be enough.

Knowing how to avoid common pitfalls, effectively present your story to an increasingly skeptical audience, and manage Q&A can make or break your new drug or device application.

In this Webinar (January 20 at 2:00 pm EDT) sponsored by "The Pink Sheet" and "The Gray Sheet" - our experts will take you through a strategic approach to preparing for an advisory committee that maximizes your chance of success, no matter your level of experience in this challenging process.

Click Here To Register!

NEW EBI Webinar: FDA Advisory Committee Survival Strategies: The Road To Approval

January 20, 2010 at 2:00 pm EDT Click Here To Register!

Getting a drug or medical device to market has never been more expensive, time-consuming, or difficult. New legislation increases the likelihood that your product will wind up in front of an FDA advisory committee. With the road to approval becoming even tougher, just having solid data to support your product may not be enough.

Knowing how to avoid common pitfalls, effectively present your story to an increasingly skeptical audience, and manage Q&A can make or break your new drug or device application.

In this Webinar (January 20 at 2:00 pm EDT) sponsored by "The Pink Sheet" and "The Gray Sheet" - our experts will take you through a strategic approach to preparing for an advisory committee that maximizes your chance of success, no matter your level of experience in this challenging process.

Click Here To Register!

NEW EBI Webinar: FDA Advisory Committee Survival Strategies: The Road To Approval

January 20, 2010 at 2:00 pm EDT Click Here To Register!

Getting a drug or medical device to market has never been more expensive, time-consuming, or difficult. New legislation increases the likelihood that your product will wind up in front of an FDA advisory committee. With the road to approval becoming even tougher, just having solid data to support your product may not be enough.

Knowing how to avoid common pitfalls, effectively present your story to an increasingly skeptical audience, and manage Q&A can make or break your new drug or device application.

In this Webinar (January 20 at 2:00 pm EDT) sponsored by "The Pink Sheet" and "The Gray Sheet" - our experts will take you through a strategic approach to preparing for an advisory committee that maximizes your chance of success, no matter your level of experience in this challenging process.

Click Here To Register!

Knowing how to avoid common pitfalls, effectively present your story to an increasingly skeptical audience, and manage Q&A can make or break your new drug or device application.

In this Webinar (January 20 at 2:00 pm EDT) sponsored by "The Pink Sheet" and "The Gray Sheet" - our experts will take you through a strategic approach to preparing for an advisory committee that maximizes your chance of success, no matter your level of experience in this challenging process.

Click Here To Register!

Fulfilling the Promise of the Scarless Surgery Revolution

 

"Fulfilling the Promise of the Scarless Surgery Revolution" Special Report publisjhed by Elsevier Business Intelligence.

When will breakthrough endoscopic technologies hit prime time?
Originally published in Medtech Insight: Medical Technology Market Intelligence®

Find out how you can get this report for FREE

Fulfilling the Promise of the Scarless Surgery Revolution

Elsevier Business Intelligence announces the publication
of a new Special Report:

Fulfilling the Promise
of the Scarless Surgery Revolution

When will breakthrough endoscopic technologies hit prime time?

Originally published in Medtech Insight: Medical Technology Market Intelligence®

Find out how you can get this report for FREE

It’s not quite Star Trek, but the future of scarless surgery is in sight, and its allure as a profitable market has companies scrambling to get in front of the revolution. But is it worth the effort? Will physicians adopt the new technology, or will it be a monumental flop? Who’s already developed scarless surgery technologies, and what’s the potential for those devices? This Special Report answers all the questions and clarifies the cloudy future of scarless surgery, whether you’re already in the space or considering its potential.

This detailed 48-page report is a must-read for every R&D, business development and investment executive in medical technology today, from surgical device manufacturers to medical imaging companies.

Prepared by Medtech Insight’s expert analysts, the report spotlights the problems and potentials of the leading scarless surgery technologies, their market potential and the probable timeline for growth.

This Special Report examines:

• Both sides of the raging debate over the future of single-incision laparoscopy
• The market potential for this revolutionary, but controversial, new procedure
• The major technologies and players in this highly-competitive device market
• The view from inside the surgeon community
• The potential for confocal microscopy and Natural Orifice Translumenal Endoscopic Surgery (NOTES) in scarless surgery
• Every factor that will impact the future of the scarless surgery revolution

Single-incision laparoscopy or natural orifice surgery: Which will win the day, or is there room for both?

The approaches to scarless surgery are diverse, each offering distinct advantages and disadvantages. This report helps you understand the specific benefits of each technology, the technical details of each, and how both device developers and the medical community view the future of this market. You'll also learn how new adjunctive tissue characterization technologies like confocal microscopy could play into endoscopy's evolving future.

What will drive physicians’ acceptance of these new technologies – and what will drive them away?

Is improved cosmesis enough of an incentive for surgeons to switch from traditional surgery to scarless surgery, or will increased costs and complex training dampen enthusiasm? Everyone has an opinion, and this report examines the pros and cons of investing time, money and effort into this space.

Who is the competition?

This report includes a complete survey of existing and developing technologies in this space, including developer, regulatory status and the product's outlook directly from top executives at these companies.

These are just some of the issues and actionable guidance included in this report. And it could only be delivered by Medtech Insight, the premier resource for medical technology intelligence, relied on by executives at 30 of the top 50 medtech companies in the world.